Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Amrubicin Study for Elderly Patients With Extensive-Disease Small-Cell Lung Cancer (ED-SCLC)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				70 and over				Pharmaceutical / Industry				D0702002 JapicCTI-060203, NCT00286169


2.		Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				CNF3140-SCLC-05004 NCT00319969


3.		Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				CNF3140-SCLC-002 NCT00375193

Last Modified: 10/29/2008 First Published: 8/12/2005


4.		Phase I Study of Amrubicin and Irinotecan in Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				Other				JMTO-LC03-03 NCT00132054

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute